We are live on ! Find out more
AET

Aetna Inc
AET

Delisted

AET was delisted on the 28th of November, 2018.

676 hedge funds and large institutions have $25.7B invested in Aetna Inc in 2014 Q2 according to their latest regulatory filings, with 69 funds opening new positions, 253 increasing their positions, 228 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed

92% more first-time investments, than exits

New positions opened: 69 | Existing positions closed: 36

35% more funds holding in top 10

Funds holding in top 10: 2027 (+7)

11% more repeat investments, than reductions

Existing positions increased: 253 | Existing positions reduced: 228

8% more capital invested

Capital invested by funds: $23.8B → $25.7B (+$1.94B)

4% more funds holding

Funds holding: 647676 (+29)

28% less call options, than puts

Call options by funds: $109M | Put options by funds: $152M

Holders
676
Holders Change
+29
Holders Change %
+4.48%
% of All Funds
19.43%
Holding in Top 10
27
Holding in Top 10 Change
+7
Holding in Top 10 Change %
+35%
% of All Funds
0.78%
New
69
Increased
253
Reduced
228
Closed
36
Calls
$109M
Puts
$152M
Net Calls
-$43.1M
Net Calls Change
-$65.5M
Name Holding Trade Value Shares
Change
Change in
Stake
State Street
1
State Street
Massachusetts
$1.82B +$20.9M +275,819 +1%
Wellington Management Group
2
Wellington Management Group
Massachusetts
$1.65B -$34.3M -452,672 -2%
Vanguard Group
3
Vanguard Group
Pennsylvania
$1.43B +$7.56M +99,880 +0.6%
Capital Research Global Investors
4
Capital Research Global Investors
California
$929M -$868M -11,472,573 -50%
JHIU
5
Janus Henderson Investors US
Colorado
$831M -$27.5M -363,635 -3%
BIT
6
BlackRock Institutional Trust
California
$799M +$23.6M +312,168 +3%
Fidelity Investments
7
Fidelity Investments
Massachusetts
$731M -$10.2M -134,867 -1%
PC
8
Paulson & Co
New York
$648M
T. Rowe Price Associates
9
T. Rowe Price Associates
Maryland
$567M -$37M -488,600 -7%
JP Morgan Chase
10
JP Morgan Chase
New York
$526M +$178M +2,345,895 +57%
Norges Bank
11
Norges Bank
Norway
$474M +$221M +2,924,604 +100%
LSV Asset Management
12
LSV Asset Management
Illinois
$457M +$12.1M +159,583 +3%
EIP
13
Epoch Investment Partners
New York
$432M -$46.2M -611,003 -10%
AllianceBernstein
14
AllianceBernstein
Tennessee
$411M +$174M +2,305,096 +83%
Northern Trust
15
Northern Trust
Illinois
$367M -$23.3M -307,263 -6%
Bank of New York Mellon
16
Bank of New York Mellon
New York
$365M -$277K -3,663 -0.1%
TCIM
17
TIAA CREF Investment Management
New York
$353M +$59.6M +786,971 +22%
Neuberger Berman Group
18
Neuberger Berman Group
New York
$331M +$31.3M +413,173 +11%
BFA
19
BlackRock Fund Advisors
California
$324M -$2.66M -35,121 -0.9%
O
20
OppenheimerFunds
New York
$312M -$20.3M -268,740 -7%
Dimensional Fund Advisors
21
Dimensional Fund Advisors
Texas
$307M -$9.03M -119,256 -3%
BG
22
BlackRock Group
United Kingdom
$306M +$1.78M +23,470 +0.6%
GCM
23
Glenview Capital Management
New York
$282M -$143M -1,887,378 -35%
BA
24
BlackRock Advisors
Delaware
$266M -$57.3M -756,588 -19%
GC
25
Greenlight Capital
New York
$261M

AET Hedge Fund Activity: Q2 2014 in Review

676 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Aetna Inc (AET) for Q2 2014, worth a combined $25.7B — up 8.1% from $23.8B a quarter earlier.

Buyers outnumbered sellers: 69 funds opened new AET positions and 36 closed out — a net gain of 33 holders — while 253 added to existing stakes and 228 trimmed.

The largest buyer was Norges Bank, adding an estimated $221M. The largest seller was Capital Research Global Investors, cutting an estimated $868M.

  • 676 institutional investors held Aetna Inc (AET) as of Q2 2014, up from 647 in Q1 2014.
  • Funds reported $25.7B of Aetna Inc stock for Q2 2014, up 8.1% quarter-over-quarter.
  • 69 funds opened new Aetna Inc positions in Q2 2014 and 36 closed out, a net change of +33 holders.
  • The largest Aetna Inc buyer in Q2 2014 was Norges Bank, an estimated $221M added.
  • The largest Aetna Inc seller in Q2 2014 was Capital Research Global Investors, an estimated $868M sold.

Based on aggregated 13F filings for Q2 2014.